scholarly article | Q13442814 |
P2093 | author name string | Bruce Barrett | |
Margaret L Wallace | |||
Jason A Ricco | |||
P2860 | cites work | Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 |
Screening for Coronary Heart Disease With Electrocardiography: U.S. Preventive Services Task Force Recommendation Statement | Q22305323 | ||
General health checks in adults for reducing morbidity and mortality from disease | Q24198193 | ||
Statins for the primary prevention of cardiovascular disease | Q24201513 | ||
Statins for the primary prevention of cardiovascular disease | Q24234813 | ||
Screening for abdominal aortic aneurysm | Q24245434 | ||
Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat | Q24564452 | ||
Coronary artery calcium score prediction of all cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis | Q26821938 | ||
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 | ||
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report | Q27861020 | ||
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE> | Q28204197 | ||
The SaM (Screening and Monitoring) approach to cardiovascular risk-reduction in primary care--cyclic monitoring and individual treatment of patients at cardiovascular risk using the electronic medical record | Q28217629 | ||
Homocysteine lowering with folic acid and B vitamins in vascular disease | Q28301516 | ||
Homocysteine lowering and cardiovascular events after acute myocardial infarction | Q28301525 | ||
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q28301815 | ||
The Cardiovascular Health Study: design and rationale | Q29614874 | ||
The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators | Q29614947 | ||
2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) | Q29617334 | ||
Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey | Q30689120 | ||
Deaths: final data for 2009. | Q30833841 | ||
Screening for abdominal aortic aneurysm: a best-evidence systematic review for the U.S. Preventive Services Task Force | Q33211375 | ||
Diabetes and lipid screening among patients in primary care: a cohort study | Q33317422 | ||
Identifying primary care patients at risk for future diabetes and cardiovascular disease using electronic health records | Q33505849 | ||
Electronic health records and clinical decision support systems: impact on national ambulatory care quality | Q33593751 | ||
Principles of the patient-centered medical home and preventive services delivery | Q33711941 | ||
The prevalence and prognostic significance of electrocardiographic abnormalities | Q33855756 | ||
Screening asymptomatic adults with resting or exercise electrocardiography: a review of the evidence for the U.S. Preventive Services Task Force | Q34022714 | ||
Appropriateness of cholesterol management in primary care by sex and level of cardiovascular risk | Q34118658 | ||
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines | Q34154032 | ||
Screening and treating adults for lipid disorders. | Q34221135 | ||
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials | Q34274829 | ||
Statins: new American guidelines for prevention of cardiovascular disease | Q43637038 | ||
Should people at low risk of cardiovascular disease take a statin? | Q43643108 | ||
Trends in hypercholesterolemia, treatment and control among United States adults | Q43765334 | ||
Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial | Q44110828 | ||
Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia | Q46147913 | ||
Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies | Q47580534 | ||
Prevalence of conventional risk factors in patients with coronary heart disease | Q47677468 | ||
Comparative effectiveness and cost-effectiveness of computed tomography screening for coronary artery calcium in asymptomatic individuals | Q48574037 | ||
Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study | Q48606433 | ||
A comparison of the Framingham and European Society of Cardiology coronary heart disease risk prediction models in the normative aging study. | Q52037493 | ||
How generalizable are coronary risk prediction models? Comparison of Framingham and two national cohorts. | Q52216715 | ||
Joint principles of the Patient-Centered Medical Home. | Q53157666 | ||
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. | Q55053962 | ||
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk | Q57413870 | ||
Electronic Health Record Use and the Quality of Ambulatory Care in the United States | Q57652923 | ||
Quality of cholesterol screening and management with respect to the National Cholesterol Education's Third Adult Treatment Panel (ATPIII) guideline in primary care practices in North Carolina | Q61784849 | ||
Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention | Q77714696 | ||
Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement | Q80140330 | ||
Atherosclerotic cardiovascular disease screening in adults: American College Of Preventive Medicine position statement on preventive practice | Q83447063 | ||
Launching accountable care organizations--the proposed rule for the Medicare Shared Savings Program | Q83755198 | ||
President's page: Disparities in cardiovascular care: finding ways to narrow the gap | Q87180093 | ||
Variation in clinical preventive services | Q34297334 | ||
Genetics of the Framingham Heart Study population | Q34458072 | ||
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project | Q34534248 | ||
Screening for abdominal aortic aneurysm: recommendation statement | Q34554685 | ||
Technology Insight: ultrasound measurement of carotid plaque--patient management, genetic research, and therapy evaluation | Q34576040 | ||
Racial and ethnic disparity in blood pressure and cholesterol measurement | Q34743087 | ||
Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis | Q34974714 | ||
Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement | Q35006693 | ||
Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force | Q35006699 | ||
Screening for high blood pressure: a review of the evidence for the U.S. Preventive Services Task Force | Q35184917 | ||
Utilization of preventive care services and their effect on cardiovascular outcomes in the United States | Q35727864 | ||
Major lipids, apolipoproteins, and risk of vascular disease | Q35771393 | ||
Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis | Q35822510 | ||
Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review | Q35867783 | ||
Multilevel analysis of the determinants of receipt of clinical preventive services among reproductive-age women | Q35936070 | ||
Trends in predicted 10-year risk of coronary heart disease and cardiovascular disease among U.S. adults from 1999 to 2010 | Q36063368 | ||
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q36429024 | ||
Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance | Q36688643 | ||
Yield of screening for coronary artery calcium in early middle-age adults based on the 10-year Framingham Risk Score: the CARDIA study | Q36879107 | ||
Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group | Q36900139 | ||
Genetic testing for inherited heart disease | Q37160655 | ||
Screening, treatment, and control of hypertension in US private physician offices, 2003-2004 | Q37166271 | ||
The relationship between electronic health record use and quality of care over time | Q37249184 | ||
Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis | Q37319748 | ||
Obesity, diets, and social inequalities | Q37488548 | ||
C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force | Q37608837 | ||
New and emerging risk factors for coronary heart disease | Q38104222 | ||
CARDIA: study design, recruitment, and some characteristics of the examined subjects | Q39292643 | ||
Variation in routine electrocardiogram use in academic primary care practice | Q39582405 | ||
Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands | Q39600920 | ||
Ethnic-specific prevalence of peripheral arterial disease in the United States | Q40230436 | ||
Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study | Q40664994 | ||
Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. | Q40882910 | ||
27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management | Q40975493 | ||
Racial and ethnic differences in patterns of treatment for acute peripheral arterial disease in the United States, 1998-2006. | Q42645965 | ||
Electronic health records and quality of care for heart failure | Q43110690 | ||
P433 | issue | 2 | |
P921 | main subject | cardiovascular disease | Q389735 |
P304 | page(s) | 371-397 | |
P577 | publication date | 2014-03-27 | |
P1433 | published in | Primary Care: Clinics in Office Practice | Q15817395 |
P1476 | title | Screening strategies for cardiovascular disease in asymptomatic adults | |
P478 | volume | 41 |
Q50104484 | Cardiovascular Disease Risk Predicts Health Perception in Prison Inmates |
Q35980419 | Communicating statin evidence to support shared decision-making |
Q90589704 | Difference Between Users and Nonusers of a Patient Portal in Health Behaviors and Outcomes: Retrospective Cohort Study |
Q92648207 | Effects of physical activity and smoking on cardio-ankle vascular index, respiratory muscle strength, and exercise performance in early normal weight adulthood: a cross-sectional study |
Q92697315 | Pain reduction and improved vascular health associated with daily consumption of an anti-inflammatory dietary supplement blend |
Q92348181 | Prevalence of positive chronic kidney Disease screening in professional male long haul drivers at risk of cardiovascular Disease in Lagos, Nigeria: a cross-section study |
Q90086728 | Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How? |
Search more.